Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study. - Lipton, Richard B.; Mosher, Linda; Fountaine, Robert J. (Pain & Therapy, 2026)